Data as of .
FMED vs INVN: which is really different?
FMED and INVN hold 0% of their weight in the same names, and FMED returned more over the year.
ETFIQ Off-Index Score: INVN scores higher
How much of it is not the index it is sold as an alternative to?
A percentile among the 379 thematic ETFs with a holdings filing. It is a position in a set, not a rating, and neither end of it is a recommendation. All thematic ETFs ranked by it · How it is computed
0% of the two portfolios are the same securities at the same weight.
What they hold in common
By the books each fund has filed, FMED and INVN hold 0% of their money in the same securities at the same weight.
| Only in FMED | Only in INVN |
|---|---|
| UCB SA 4.75% | ROBLOX CORP 2.56% |
| LIFESTANCE HEALTH GROUP INC 4.29% | ZEBRA TECHNOLOGIES CORP 2.38% |
| DANAHER CORP 3.43% | EXPEDIA GROUP INC 2.29% |
| 10X GENOMICS INC 3.12% | MAPLEBEAR INC 2.25% |
| INTUITIVE SURGICAL INC 2.93% | BLOCK INC 2.23% |
| COGENT BIOSCIENCES INC 2.86% | ZSCALER INC 2.21% |
| ALNYLAM PHARMACEUTICALS INC 2.80% | BILL HOLDINGS INC 2.18% |
| ARGENX SE 2.79% | BIOGEN INC 2.18% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026 and May 31, 2026.
Performance, window by window
| Window | Total return | vs the S&P 500 | vs the Nasdaq-100 | |||
|---|---|---|---|---|---|---|
| FMED | INVN | FMED | INVN | FMED | INVN | |
| 3 months | +21.3% | +24.7% | +19.0 pts | +22.4 pts | +23.7 pts | +27.2 pts |
| 6 months | +32.3% | +37.7% | +14.3 pts | +19.6 pts | +8.0 pts | +13.4 pts |
| 1 year | +28.3% | +20.7% | +11.7 pts | +4.2 pts | +6.5 pts | −1.1 pts |
| 3 years | +39.6% | not published | −38.8 pts | not published | −58.5 pts | not published |
| Since launch | +25.8% | +29.2% | −57.6 pts | −2.8 pts | −78.1 pts | −11.9 pts |
| FMED Fidelity Disruptive Medicine ETF Holds 68 stocks in broad innovation and megatrends, 25% of its weight in S&P 500 companies | INVN Alger Russell Innovation ETF Holds 50 stocks in broad innovation and megatrends, 32% of its weight in S&P 500 companies | |
|---|---|---|
| Issuer | Fidelity | Alger |
| Theme | Broad innovation and megatrends | Broad innovation and megatrends |
| In the S&P 500 | 25.4% | 32.5% |
| Active share vs the S&P 500 | 97.1% | 98.5% |
| In the Nasdaq-100 | 8.7% | 9.8% |
| Holdings | 68 | 50 |
| Top ten, share of the fund | 31.5% | 22.6% |
| Expense ratio | 0.50% | 0.55% |
| Fee for the differing part | 0.51% | 0.56% |
| Total return, 1 year | +28.3% | +20.7% |
| vs the S&P 500 | +11.7 pts | +4.2 pts |
| vs the Nasdaq-100 | +6.5 pts | −1.1 pts |
| Below its high | −3.8% | −5.6% |
| Net assets | $52m | $10m |
FMED in plain words
By weight, 25% of FMED's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 97%. The top ten holdings are 32% of the fund across 68 positions, as filed for May 31, 2026. Over the year to Sep 18, 2026 the fund returned +28.3% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 11.7 pts.
INVN in plain words
By weight, 32% of INVN's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 23% of the fund across 50 positions, as filed for Jun 30, 2026. Over the year to Sep 18, 2026 the fund returned +20.7% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 4.2 pts. It sits 5.6% below its all-time high of Sep 3, 2026.
Questions people ask
- Do FMED and INVN hold the same stocks?
- By their latest filings, 0% of their books are the same securities at the same weight, which is mostly different names. Overlap is the sum of the smaller weight of every security they share.
- Which is more different from the S&P 500, FMED or INVN?
- FMED has 25% of its weight in S&P 500 names and INVN has 32%, so INVN differs more from the index.
- Which is cheaper, FMED or INVN?
- FMED charges 0.50% a year and INVN charges 0.55%, so FMED is cheaper. Fees come from each fund's prospectus.
Other comparisons
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, FMED against INVN, data as of Sep 18, 2026. https://etfiq.com/compare/themes/fmed-vs-invn Free to use with attribution; the underlying files are at Open data.